Literature DB >> 16612588

How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.

Barbara M Fischer1, Minna W B Olsen, Carsten D Ley, Thomas L Klausen, Jann Mortensen, Liselotte Højgaard, Paul E G Kristjansen.   

Abstract

PURPOSE: Positron emission tomography (PET) has gained widespread use in cancer diagnosis and treatment, but how many malignant cells are required for a tumour to be detected by PET?
METHODS: Three human cancer cell lines [glioblastoma and two subtypes of small cell lung cancer (SCLC)] in concentrations from 10(4) to 10(7) were seeded on six-well plates or plastic tubes and treated with [(18)F]fluorodeoxy-glucose (FDG) in vitro. FDG retention was measured in a PET/CT scanner and in a calibrated well counter. The clinical situation was simulated using a cylinder phantom with a background concentration of FDG.
RESULTS: The theoretical detection limit was found to be around 10(5) malignant cells. In a cylinder phantom the detection limit was increased by a factor of 10. The FDG retention by the glioblastoma cell line was significantly higher than the activity of the SCLC cell line. FDG retention measured by PET and a gamma counter was closely correlated to the number of cells and a linear relationship was found. DISCUSSION: The detection limit of PET is in the magnitude of 10(5) to 10(6) malignant cells. The experimental set-up was robust and well suited as a platform for further investigations of factors influencing the detection limit of PET.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612588     DOI: 10.1007/s00259-005-0038-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  11 in total

Review 1.  The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology.

Authors:  J F Vansteenkiste; S G Stroobants
Journal:  Eur Respir J       Date:  2001-04       Impact factor: 16.671

2.  Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro.

Authors:  M W Pedersen; S Holm; E L Lund; L Højgaard; P E Kristjansen
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

3.  The natural history of lung cancer: a review based on rates of tumour growth.

Authors:  D M Geddes
Journal:  Br J Dis Chest       Date:  1979-01

4.  Endoprobe: a system for radionuclide-guided endoscopy.

Authors:  Raymond R Raylman; Amarnath Srinivasan
Journal:  Med Phys       Date:  2004-12       Impact factor: 4.071

5.  An intra-operative positron probe with background rejection capability for FDG-guided surgery.

Authors:  Seiichi Yamamoto; Keiichi Matsumoto; Setsu Sakamoto; Kazumasa Tarutani; Kotaro Minato; Michio Senda
Journal:  Ann Nucl Med       Date:  2005-02       Impact factor: 2.668

6.  Evaluation of ion-implanted-silicon detectors for use in intraoperative positron-sensitive probes.

Authors:  R R Raylman; R L Wahl
Journal:  Med Phys       Date:  1996-11       Impact factor: 4.071

7.  Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.

Authors:  U Haberkorn; I Morr; F Oberdorfer; M E Bellemann; J Blatter; A Altmann; B Kahn; G van Kaick
Journal:  J Nucl Med       Date:  1994-11       Impact factor: 10.057

8.  Role of F18-FDG PET for monitoring of radiochemotherapy -- estimation of detectable number of tumour cells.

Authors:  J Ruf; H Amthauer; H Oettle; T Steinmüller; M Plotkin; U Pelzer; H-J Scholman; R Felix; P Wust
Journal:  Onkologie       Date:  2004-06

9.  Quantitation of cell number by a positron emission tomography reporter gene strategy.

Authors:  Helen Su; Ashley Forbes; Sanjiv S Gambhir; Jonathan Braun
Journal:  Mol Imaging Biol       Date:  2004 May-Jun       Impact factor: 3.488

Review 10.  Positron emission tomography in lung cancer.

Authors:  I Ho Shon; M J O'doherty; M N Maisey
Journal:  Semin Nucl Med       Date:  2002-10       Impact factor: 4.446

View more
  19 in total

1.  PET/CT in head and neck cancer.

Authors:  Liselotte Højgaard; Lena Specht
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09       Impact factor: 9.236

2.  Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor.

Authors:  Mai Johnson; Breanne D W Karanikolas; Saul J Priceman; Russell Powell; Margaret E Black; Hsiao-Ming Wu; Johannes Czernin; Sung-Cheng Huang; Lily Wu
Journal:  J Nucl Med       Date:  2009-04-16       Impact factor: 10.057

Review 3.  Positron emission tomography in the follow-up of cutaneous malignant melanoma patients: a systematic review.

Authors:  Maria Danielsen; Liselotte Højgaard; Andreas Kjær; Barbara Mb Fischer
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

4.  Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.

Authors:  Mathieu Hatt; John A Lee; Charles R Schmidtlein; Issam El Naqa; Curtis Caldwell; Elisabetta De Bernardi; Wei Lu; Shiva Das; Xavier Geets; Vincent Gregoire; Robert Jeraj; Michael P MacManus; Osama R Mawlawi; Ursula Nestle; Andrei B Pugachev; Heiko Schöder; Tony Shepherd; Emiliano Spezi; Dimitris Visvikis; Habib Zaidi; Assen S Kirov
Journal:  Med Phys       Date:  2017-05-18       Impact factor: 4.071

Review 5.  Rational development of radiopharmaceuticals for HIV-1.

Authors:  Chuen-Yen Lau; Frank Maldarelli; William C Eckelman; Ronald D Neumann
Journal:  Nucl Med Biol       Date:  2014-01-17       Impact factor: 2.408

Review 6.  In Vivo Imaging-Driven Approaches to Study Virus Dissemination and Pathogenesis.

Authors:  Pradeep D Uchil; Kelsey A Haugh; Ruoxi Pi; Walther Mothes
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

7.  Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography.

Authors:  Edward A Weinstein; Alvaro A Ordonez; Vincent P DeMarco; Allison M Murawski; Supriya Pokkali; Elizabeth M MacDonald; Mariah Klunk; Ronnie C Mease; Martin G Pomper; Sanjay K Jain
Journal:  Sci Transl Med       Date:  2014-10-22       Impact factor: 17.956

8.  TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT.

Authors:  Yihui Chen; Munawwar Sajjad; Yanfang Wang; Carrie Batt; Hani A Nabi; Ravindra K Pandey
Journal:  ACS Med Chem Lett       Date:  2010-11-23       Impact factor: 4.345

9.  Single-cell tracking with PET using a novel trajectory reconstruction algorithm.

Authors:  Keum Sil Lee; Tae Jin Kim; Guillem Pratx
Journal:  IEEE Trans Med Imaging       Date:  2014-11-21       Impact factor: 10.048

10.  18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?

Authors:  Ruoh-Fang Yen; Ke-Cheng Chen; Jang-Ming Lee; Yeun-Chung Chang; Jane Wang; Mei-Fang Cheng; Yen-Wen Wu; Yung-Chie Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-19       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.